ion channel blockers (Allergan)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameion channel blockers (Allergan)
Drug Alias Nameglaucoma therapy (Cambridge/Allergan)ion channel blocker (Cambridge/Allergan)ion channel blockers (CeNeS/Allergan)glaucoma therapy (CeNeS/Allergan)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonistsSodium channels blockers
TargetsGlutamate [NMDA] receptorSodium channels
Therapy Area/IndicationsGlaucomaEye Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCeNeS Pharmaceuticals plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCeNeS Pharmaceuticals plcAllergan Inc
Active IndicationsN/A
Inactive IndicationsGlaucomaEye Diseases

Other Information

ATC CodeN/A
Related LinksN/A